Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
58,295,157
-
Share change
-
+13,772,190
-
Total reported value
-
$55,964,690
-
Put/Call ratio
-
24%
-
Price per share
-
$0.96
-
Number of holders
-
74
-
Value change
-
+$13,343,043
-
Number of buys
-
30
-
Number of sells
-
33
Institutional Holders of SPECTRUM PHARMACEUTICALS INC - COM (SPPI) as of Q2 2023
As of 30 Jun 2023,
SPECTRUM PHARMACEUTICALS INC - COM (SPPI) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,295,157 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, KENNEDY CAPITAL MANAGEMENT LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, Ergoteles LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.